Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1202
Peer-review started: December 26, 2022
First decision: February 21, 2023
Revised: March 21, 2023
Accepted: April 25, 2023
Article in press: April 25, 2023
Published online: June 27, 2023
Processing time: 171 Days and 10.8 Hours
Anastomotic leakage (AL) following rectal cancer surgery is an important cause of mortality and recurrence. Although transanal drainage tubes (TDTs) are expected to reduce the rate of AL, their preventive effects are controversial.
To reveal the effect of TDT in patients with symptomatic AL after rectal cancer surgery.
A systematic literature search was performed using the PubMed, Embase, and Cochrane Library databases. We included randomized controlled trials (RCTs) and prospective cohort studies (PCSs) in which patients were assigned to two groups depending on the use or non-use of TDT and in which AL was evaluated. The results of the studies were synthesized using the Mantel-Haenszel random-effects model, and a two-tailed P value > 0.05 was considered statistically significant.
Three RCTs and two PCSs were included in this study. Symptomatic AL was examined in all 1417 patients (712 with TDT), and TDTs did not reduce the symptomatic AL rate. In a subgroup analysis of 955 patients without a diverting stoma, TDT reduced the symptomatic AL rate (odds ratio = 0.50, 95% confidence interval: 0.29–0.86, P = 0.012).
TDT may not reduce AL overall among patients undergoing rectal cancer surgery. However, patients without a diverting stoma may benefit from TDT placement.
Core Tip: Anastomotic leakage (AL) following rectal cancer surgery is a serious problem, and a transanal drainage tube (TDT) is expected to reduce AL. However, the preventive effects of TDT placement are controversial. Thus, we performed a meta-analysis of three randomized controlled trials and two prospective cohort studies. A systematic literature search was performed, and the results of the meta-analysis were synthesized using the Mantel-Haenszel random-effects model. Overall, TDT did not significantly reduce the symptomatic AL rate, but it did among patients without a diverting stoma.